Clinical Potential of 18F-fluoroestradiol (FES) PET Imaging for Patients with Metastatic ILC

Loading Events

« All Events

  • This event has passed.

Clinical Potential of 18F-fluoroestradiol (FES) PET Imaging for Patients with Metastatic ILC

December 2, 2021 @ 12:00 pm - 1:00 pm EST

Free
FES-PET webinar

The Lobular Breast Cancer Alliance will present the educational webinar Clinical Potential of 18F-fluoroestradiol (FES) PET Imaging for Patients with Metastatic Lobular Breast Cancer on December 2, 2021. The pre-recorded webinar, moderated by LBCA Executive Director Laurie Hutcheson, will feature radiologist and LBCA Scientific Advisory Board Member Dr. Gary Ulaner, oncologist Dr. Hannah Linden, and a patient with metastatic ILC who all have experience with Fluoroestradiol (FES) used with Positron Emission Tomography (PET). FES/PET is a new imaging resource being used in metastatic ILC imaging.

The intent of the educational webinar is to share information about its use with metastatic ILC to assess hormone treatment efficacy, and to discuss other potential applications the drug may hold for imaging in treating patients with ILC. This webinar is made possible with a sponsorship from GE Healthcare.

The event will premiere on LBCA’s Facebook page. You can set a reminder for the event as well.

Details

Date:
December 2, 2021
Time:
12:00 pm - 1:00 pm EST
Cost:
Free
Website:
https://www.facebook.com/lobularbreastcanceralliance/posts/1508419426200394

Organizer

Lobular Breast Cancer Alliance
Email:
info@lobularbreastcancer.org
Scroll to Top

Join Us

Subscribe for the Latest News & Updates​

  • This field is for validation purposes and should be left unchanged.